Skip to main content

CVS Health Value Stock - Dividend - Research Selection

Cvs health

ISIN: US1266501006 , WKN: 859034

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?

2024-11-25
Israel "Izzy" Englander's net worth tops $14 billion. The billionaire bought one high-yield dividend stock hand over fist in Q3. If you glance at Englander's purchases for Millennium Management in Q3, you'll probably notice he added significantly to several existing holdings.

CVS Health Corp. stock outperforms competitors on strong trading day

2024-11-22
CVS Health Corp. stock outperforms competitors on strong trading day

Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet

2024-11-22
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

CVS Health Corp. stock rises Thursday, still underperforms market

2024-11-21
CVS Health Corp. stock rises Thursday, still underperforms market

Major companies that are also popular short-selling stocks

2024-11-21
Investor confidence in certain major companies has propelled markets higher, but there are also those betting against big-name stocks through short selling.

Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy

2024-11-20
Top F500IL dividend stocks like AT&T, Altria, and Energy Transfer promise gains. Read why Energy Transfer stands as a safer choice.

Is CVS Health Stock an Underrated Buy?

2024-11-20
Shares of healthcare giant CVS Health (NYSE: CVS) have been in a free fall this year. The company has failed to impress investors with its earnings numbers and has slashed its guidance multiple times. Is CVS stock worth the risk?

Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day

2024-11-20
Taiwan Semiconductor and CVS Health have been highlighted as Zacks Bull and Bear of the Day.

Bear of the Day: CVS Health (CVS)

2024-11-20
Guidance cuts stemming from weak quarterly results have caused shares to travel a rocky road in 2024.

XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)

2024-11-20
We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.